{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:16:00Z","timestamp":1776860160673,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["NR008252"],"award-info":[{"award-number":["NR008252"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00520-018-4627-x","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T06:24:27Z","timestamp":1547015067000},"page":"3357-3364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neuropathic symptoms, physical and emotional well-being, and quality of life at the end of life"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3757-5823","authenticated-orcid":false,"given":"Cindy","family":"Tofthagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"Visovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Dominic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"4627_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/082585979601200102","volume":"12","author":"F Anderson","year":"1996","unstructured":"Anderson F, Downing GM, Hill J, Casorso L, Lerch N (1996) Palliative performance scale (PPS): a new tool. J Palliat Care 12:5\u201311","journal-title":"J Palliat Care"},{"key":"4627_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10549-016-3939-0","volume":"159","author":"T Bao","year":"2016","unstructured":"Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159:327\u2013333","journal-title":"Breast Cancer Res Treat"},{"key":"4627_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.12788\/jcso.0086","volume":"12","author":"A Beijers","year":"2014","unstructured":"Beijers A, Mols F, Dercksen W, Driessen C, Vreugdenhil G (2014) Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy. J Community Support Oncol 12:401\u2013406","journal-title":"J Community Support Oncol"},{"key":"4627_CR4","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00520-015-3032-y","volume":"24","author":"AJ Beijers","year":"2016","unstructured":"Beijers AJ, Vreugdenhil G, Oerlemans S, Eurelings M, Minnema MC, Eeltink CM, van de Poll-Franse LV, Mols F (2016) Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice. Support Care Cancer 24:2411\u20132420","journal-title":"Support Care Cancer"},{"key":"4627_CR5","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1093\/annonc\/mdr583","volume":"23","author":"M Brundage","year":"2012","unstructured":"Brundage M, Gropp M, Mefti F, Mann K, Lund B, Gebski V, Wolfram G, Reed N, Pignata S, Ferrero A, Brown C, Eisenhauer E, Pujade-Lauraine E (2012) Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial. Annals of oncology : official journal of the European Society for Medical Oncology 23:2020\u20132027","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"key":"4627_CR6","unstructured":"Centers for Medicare & Medicaid Services (2008 ) Minimum data set version 2.0 for nursing home resident assessment and care screening. In: Editor (ed)^(eds) Book Minimum Data Set Version 2.0 for Nursing Home Resident Assessment and Care creening. CMS, City"},{"key":"4627_CR7","first-page":"503","volume":"3","author":"CS Chan","year":"2015","unstructured":"Chan CS, Slaughter SE, Jones CA, Wagg AS (2015) Greater independence in activities of daily living is associated with higher health-related quality of life scores in nursing home residents with dementia. Healthcare (Basel, Switzerland) 3:503\u2013518","journal-title":"Healthcare (Basel, Switzerland)"},{"key":"4627_CR8","first-page":"727","volume":"54","author":"D Chowdhury","year":"2006","unstructured":"Chowdhury D, Patel N (2006) Approach to a case of autonomic peripheral neuropathy. J Assoc Physicians India 54:727\u2013732","journal-title":"J Assoc Physicians India"},{"key":"4627_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00520-011-1336-0","volume":"20","author":"CM Driessen","year":"2012","unstructured":"Driessen CM, de Kleine-Bolt KM, Vingerhoets AJ, Mols F, Vreugdenhil G (2012) Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients: the introduction of a new measure. Support Care Cancer 20:877\u2013881","journal-title":"Support Care Cancer"},{"key":"4627_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ygyno.2014.09.016","volume":"135","author":"NP Ezendam","year":"2014","unstructured":"Ezendam NP, Pijlman B, Bhugwandass C, Pruijt JF, Mols F, Vos MC, Pijnenborg JM, van de Poll-Franse LV (2014) Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry. Gynecol Oncol 135:510\u2013517","journal-title":"Gynecol Oncol"},{"key":"4627_CR11","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1097\/MJT.0b013e3181cea0ef","volume":"18","author":"A Ghose","year":"2011","unstructured":"Ghose A, Tariq Z, Taj A, Chaudhary R (2011) Acute dyspnea from treatment of AL amyloidisis with bortezomib. Am J Ther 18:e123\u2013e125","journal-title":"Am J Ther"},{"key":"4627_CR12","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","volume":"32","author":"DL Hershman","year":"2014","unstructured":"Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL, American Society of Clinical O (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32:1941\u20131967","journal-title":"J Clin Oncol"},{"key":"4627_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3747\/co.21.1984","volume":"21","author":"JS Hong","year":"2014","unstructured":"Hong JS, Tian J, Wu LH (2014) The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients. Curr Oncol 21:174\u2013180","journal-title":"Curr Oncol"},{"key":"4627_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejon.2015.10.007","volume":"21","author":"KH Hwang","year":"2016","unstructured":"Hwang KH, Cho OH, Yoo YS (2016) Symptom clusters of ovarian cancer patients undergoing chemotherapy, and their emotional status and quality of life. Eur J Oncol Nurs 21:215\u2013222","journal-title":"Eur J Oncol Nurs"},{"key":"4627_CR15","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","volume":"185","author":"S Katz","year":"1963","unstructured":"Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function. JAMA 185:914\u2013919","journal-title":"JAMA"},{"key":"4627_CR16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.4040\/jkan.2015.45.5.661","volume":"45","author":"KY Kim","year":"2015","unstructured":"Kim KY, Lee SH, Kim JH, Oh PJ (2015) Disturbance in ADL from chemotherapy-induced peripheral neuropathy and quality of life in cancer patients: the mediating effect of psychological distress. J Korean Acad Nurs 45:661\u2013670","journal-title":"J Korean Acad Nurs"},{"key":"4627_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.pmn.2018.01.001","volume":"19","author":"R Knoerl","year":"2018","unstructured":"Knoerl R, Chornoby Z, Smith EML (2018) Estimating the frequency, severity, and clustering of SPADE symptoms in chronic painful chemotherapy-induced peripheral neuropathy. Pain Manag Nurs 19:354\u2013365","journal-title":"Pain Manag Nurs"},{"key":"4627_CR18","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s11136-013-0379-8","volume":"22","author":"EM Lavoie Smith","year":"2013","unstructured":"Lavoie Smith EM, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL (2013) Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Qual Life Res 22:2787\u20132799","journal-title":"Qual Life Res"},{"key":"4627_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF00435396","volume":"3","author":"SC McMillan","year":"1994","unstructured":"McMillan SC, Mahon M (1994) Measuring quality of life in hospice patients using a newly developed Hospice Quality of Life Index. Qual Life Res 3:437\u2013447","journal-title":"Qual Life Res"},{"key":"4627_CR20","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1188\/02.ONF.1421-1428","volume":"29","author":"SC McMillan","year":"2002","unstructured":"McMillan SC, Small BJ (2002) Symptom distress and quality of life in patients with cancer newly admitted to hospice home care. Oncol Nurs Forum 29:1421\u20131428","journal-title":"Oncol Nurs Forum"},{"key":"4627_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1046\/j.1523-5394.1998.00023.x","volume":"6","author":"SC McMillan","year":"1998","unstructured":"McMillan SC, Weitzner M (1998) Quality of life in cancer patients: use of a revised Hospice Index. Cancer Pract 6:282\u2013288","journal-title":"Cancer Pract"},{"key":"4627_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/NCC.0b013e3181f70aee","volume":"34","author":"SC McMillan","year":"2011","unstructured":"McMillan SC, Small BJ, Haley WE (2011) Improving hospice outcomes through systematic assessment: a clinical trial. Cancer Nurs 34:89\u201397","journal-title":"Cancer Nurs"},{"key":"4627_CR23","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.4187\/respcare.04174","volume":"60","author":"J Mohammed","year":"2015","unstructured":"Mohammed J, Meeus M, Derom E, Da Silva H, Calders P (2015) Evidence for autonomic function and its influencing factors in subjects with COPD: a systematic review. Respir Care 60:1841\u20131851","journal-title":"Respir Care"},{"key":"4627_CR24","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","volume":"31","author":"F Mols","year":"2013","unstructured":"Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV (2013) Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol 31:2699\u20132707","journal-title":"J Clin Oncol"},{"key":"4627_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11764-015-0427-1","volume":"9","author":"F Mols","year":"2015","unstructured":"Mols F, Beijers AJ, Vreugdenhil G, Verhulst A, Schep G, Husson O (2015) Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry. J Cancer surviv 9:512\u2013522","journal-title":"J Cancer surviv"},{"key":"4627_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejon.2017.07.007","volume":"30","author":"JH Nho","year":"2017","unstructured":"Nho JH, Reul Kim S, Nam JH (2017) Symptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy. Eur J Oncol Nurs 30:8\u201314","journal-title":"Eur J Oncol Nurs"},{"key":"4627_CR27","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/0959-8049(94)90182-1","volume":"30A","author":"RK Portenoy","year":"1994","unstructured":"Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L et al (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A:1326\u20131336","journal-title":"Eur J Cancer"},{"key":"4627_CR28","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00520-016-3545-z","volume":"25","author":"SY Rha","year":"2017","unstructured":"Rha SY, Lee J (2017) Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life. Support Care Cancer 25:1519\u20131527","journal-title":"Support Care Cancer"},{"key":"4627_CR29","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1007\/s00520-012-1492-x","volume":"20","author":"K Shimozuma","year":"2012","unstructured":"Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Katsumata N, Kuranami M, Suemasu K, Watanabe T, Hausheer FH (2012) Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial. Support Care Cancer 20:3355\u20133364","journal-title":"Support Care Cancer"},{"key":"4627_CR30","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EM Smith","year":"2013","unstructured":"Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. Jama 309:1359\u20131367","journal-title":"Jama"},{"key":"4627_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1188\/14.ONF.669-679","volume":"41","author":"EM Smith","year":"2014","unstructured":"Smith EM, Campbell G, Tofthagen C, Kottschade L, Collins ML, Warton C, Ghosh B, Ronis DL, Mallory GA, Visovsky C (2014) Nursing knowledge, practice patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum 41:669\u2013679","journal-title":"Oncol Nurs Forum"},{"key":"4627_CR32","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1002\/cncr.27463","volume":"118","author":"MD Stubblefield","year":"2012","unstructured":"Stubblefield MD, McNeely ML, Alfano CM, Mayer DK (2012) A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy. Cancer 118:2250\u20132260","journal-title":"Cancer"},{"key":"4627_CR33","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1188\/10.CJON.E22-E28","volume":"14","author":"C Tofthagen","year":"2010","unstructured":"Tofthagen C (2010) Patient perceptions associated with chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 14:E22\u2013E28","journal-title":"Clin J Oncol Nurs"},{"key":"4627_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/NCC.0b013e3181e212b4","volume":"33","author":"C Tofthagen","year":"2010","unstructured":"Tofthagen C, McMillan SC (2010) Pain, neuropathic symptoms, and physical and mental well-being in persons with cancer. Cancer Nurs 33:437\u2013444","journal-title":"Cancer Nurs"},{"key":"4627_CR35","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1007\/s00520-013-1905-5","volume":"21","author":"C Tofthagen","year":"2013","unstructured":"Tofthagen C, Donovan KA, Morgan MA, Shibata D, Yeh Y (2013) Oxaliplatin-induced peripheral neuropathy\u2019s effects on health-related quality of life of colorectal cancer survivors. Support Care Cancer 21:3307\u20133313","journal-title":"Support Care Cancer"},{"key":"4627_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0885-3924(03)00074-5","volume":"25","author":"JE Tranmer","year":"2003","unstructured":"Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K (2003) Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manag 25:420\u2013429","journal-title":"J Pain Symptom Manag"},{"key":"4627_CR37","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/j.pain.0000000000000404","volume":"157","author":"L Ventzel","year":"2016","unstructured":"Ventzel L, Jensen AB, Jensen AR, Jensen TS, Finnerup NB (2016) Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel. Pain 157:560\u2013568","journal-title":"Pain"},{"key":"4627_CR38","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1188\/07.CJON.901-913","volume":"11","author":"C Visovsky","year":"2007","unstructured":"Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C (2007) Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 11:901\u2013913","journal-title":"Clin J Oncol Nurs"},{"key":"4627_CR39","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1200\/JCO.2016.71.3552","volume":"35","author":"KM Winters-Stone","year":"2017","unstructured":"Winters-Stone KM, Horak F, Jacobs PG, Trubowitz P, Dieckmann NF, Stoyles S, Faithfull S (2017) Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol 35:2604\u20132612","journal-title":"J Clin Oncol"},{"key":"4627_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3892\/br.2017.851","volume":"6","author":"X Zhang","year":"2017","unstructured":"Zhang X, Chen WW, Huang WJ (2017) Chemotherapy-induced peripheral neuropathy. Biomed Rep 6:267\u2013271","journal-title":"Biomed Rep"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4627-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T15:19:08Z","timestamp":1589642348000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4627-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["4627"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4627-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"assertion":[{"value":"25 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The project was approved by the administrators of the two involved hospices and by the University of South Florida Institutional Review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}